|
|
| Research article summary (published 30 Aug 2009): |
Effects of prednisolone on skeletal muscle contractility in mdx mice.
Full Abstract
Current treatment for Duchenne muscular dystrophy (DMD) is chronic administration of the glucocorticoid prednisolone. Prednisolone improves muscle strength in boys with DMD, but the mechanism is unknown. The purpose of this study was to determine how prednisolone improves muscle strength by examining muscle contractility in dystrophic mice over time and in conjunction with eccentric injury. Mdx mice began receiving prednisolone (n = 23) or placebo (n = 16) at 5 weeks of age. Eight weeks of prednisolone increased specific force of the extensor digitorum longus muscle 26%, but other parameters of contractility were not affected. Prednisolone also improved the histological appearance of muscle by decreasing the number of centrally nucleated fibers. Prednisolone treatment did not affect force loss during eccentric contractions or recovery of force following injury. These data are of clinical relevance, because the increase in muscle strength in boys with DMD taking prednisolone does not appear to occur via the same mechanism in dystrophic mice.
Author information
Author/s: Baltgalvis, Kristen A (KA); Call, Jarrod A (JA); Nikas, Jason B (JB); Lowe, Dawn A (DA);
Affiliation: Department of Biochemistry, University of Minnesota Medical School, 321 Church St. SE, Jackson Hall, 6-155, Minneapolis, Minnesota 55455, USA. kb(-atsign-)ddt.biochem.umn.edu
Journal and publication information
Publication Type: In Vitro; Journal Article
Journal: Muscle & nerve (Muscle Nerve), published in United States. (Language: eng)
Reference: 2009-Sep; vol 40 (issue 3) : pp 443-54
Dates: Created 2009/08/31; Completed 2009/10/06;
PMID: 19618428, status: MEDLINE (last retrieval date: 10/6/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Interaction of glucocorticoids and activity patterns affect muscle function.
30 Jan 1995 - Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy.
7 Apr 2008 - Functional improvement of dystrophic muscle by myostatin blockade.
26 Nov 2002 - Weekly oral prednisolone improves survival and strength in male mdx mice.
30 Dec 2006 - [Malignant hyperthermia of Duchenne muscular dystrophy: application of clinical grading scale and caffeine contracture of skinned muscle fibers]
29 Apr 2000 - Influence of hindlimb suspension on calcium-induced contraction characteristics in dystrophin-deficient animals.
29 Jun 2007 - Poloxamer 188 failed to prevent exercise-induced membrane breakdown in mdx skeletal muscle fibers.
19 Nov 2006 - Endurance capacity in maturing mdx mice is markedly enhanced by combined voluntary wheel running and green tea extract.
24 Jun 2008 - Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy.
18 Dec 2006 - Impaired regeneration of dystrophin-deficient muscle fibers is caused by exhaustion of myogenic cells.
30 May 2002
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.